Our present findings indicate that higher levels of IL-1 β and lower levels of adiponectin are the factors increasing the likelihood of MCI developing in elderly patients with type 2 diabetes, according to a multivariable model. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.